Bolazine capronate
Clinical data | |
---|---|
Trade names | Roxilon Inject |
Other names | Bolazine caproate; Bolazine hexanoate; Di(drostanolone capronate) azine; 2α-Methyl-5α-androstan-17β-ol-3-one 17β-hexanoate azine |
Routes of administration | Intramuscular injection |
Identifiers | |
IUPAC name
| |
ChemSpider | |
Chemical and physical data | |
Formula | C52H84N2O4 |
Molar mass | 801.254 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Bolazine capronate (INN) (brand name Roxilon Inject), also known as bolazine caproate or bolazine hexanoate, as well as di(drostanolone capronate) azine or 2α-methyl-5α-androstan-17β-ol-3-one 17β-hexanoate azine, is a synthetic, injected androgen/anabolic steroid (AAS) and derivative of dihydrotestosterone (DHT).[1][2] It is an androgen ester – specifically, the C17β hexanoate ester of bolazine.[1][2]
See also
References
- 1 2 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 653–. ISBN 978-1-4757-2085-3.
- 1 2 García-Manso JM, Valverde Esteve T (2016). Consequences of the Use of Anabolic-Androgenic Steroids on Female Athletes' Fertility. pp. 229–238. doi:10.1007/978-1-4939-3402-7_14. ISBN 978-1-4939-3400-3.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.